Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]

Barabássy Á, Sebe B, Acsai K, et al. Neuropsychiatr Dis Treat. 2021;17:957–970. The authors have advised that there are errors in the first row of Table 5 on page 963. Cariprazine 4.5 mg column, the value “1 (0.0)” should&nbsp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
cariprazine
atypical antipsychotic
schizophrenia
safety and tolerability
post hoc analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/cf336b8f9cd74908af6e74a46e31c7e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cf336b8f9cd74908af6e74a46e31c7e7
record_format dspace
spelling oai:doaj.org-article:cf336b8f9cd74908af6e74a46e31c7e72021-12-02T14:36:43ZSafety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]1178-2021https://doaj.org/article/cf336b8f9cd74908af6e74a46e31c7e72021-05-01T00:00:00Zhttps://www.dovepress.com/corrigendum-safety-and-tolerability-of-cariprazine-in-patients-with-sc-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Barabássy Á, Sebe B, Acsai K, et al. Neuropsychiatr Dis Treat. 2021;17:957–970. The authors have advised that there are errors in the first row of Table 5 on page 963. Cariprazine 4.5 mg column, the value “1 (0.0)” should read “1 (0.2)”. Cariprazine 6 mg column, “2 (0.0)” should read “2 (0.3)”. Total 1.5-6 mg/d column, “0” should read “3 (0.1)”. The authors apologize for these errors. Read the original articleBarabássy ÁSebe BAcsai KLaszlovszky ISzatmári BEarley WRNémeth GDove Medical Pressarticlecariprazineatypical antipsychoticschizophreniasafety and tolerabilitypost hoc analysisNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 1481-1482 (2021)
institution DOAJ
collection DOAJ
language EN
topic cariprazine
atypical antipsychotic
schizophrenia
safety and tolerability
post hoc analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle cariprazine
atypical antipsychotic
schizophrenia
safety and tolerability
post hoc analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Barabássy Á
Sebe B
Acsai K
Laszlovszky I
Szatmári B
Earley WR
Németh G
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
description Barabássy Á, Sebe B, Acsai K, et al. Neuropsychiatr Dis Treat. 2021;17:957–970. The authors have advised that there are errors in the first row of Table 5 on page 963. Cariprazine 4.5 mg column, the value “1 (0.0)” should read “1 (0.2)”. Cariprazine 6 mg column, “2 (0.0)” should read “2 (0.3)”. Total 1.5-6 mg/d column, “0” should read “3 (0.1)”. The authors apologize for these errors. Read the original article
format article
author Barabássy Á
Sebe B
Acsai K
Laszlovszky I
Szatmári B
Earley WR
Németh G
author_facet Barabássy Á
Sebe B
Acsai K
Laszlovszky I
Szatmári B
Earley WR
Németh G
author_sort Barabássy Á
title Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
title_short Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
title_full Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
title_fullStr Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
title_full_unstemmed Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
title_sort safety and tolerability of cariprazine in patients with schizophrenia: a pooled analysis of eight phase ii/iii studies [corrigendum]
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/cf336b8f9cd74908af6e74a46e31c7e7
work_keys_str_mv AT barabassya safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT sebeb safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT acsaik safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT laszlovszkyi safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT szatmarib safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT earleywr safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
AT nemethg safetyandtolerabilityofcariprazineinpatientswithschizophreniaapooledanalysisofeightphaseiiiiistudiescorrigendum
_version_ 1718391036878782464

Ejemplares similares